| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tempest Therapeutics, Inc. (TPST) has 5 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. TPST is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.6K | $536.5K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2015 | Young Jeffrey E | Chief Financial Officer | Buy | 3,450 | $10.70 | $36,915.00 | +1,150% | |
| Oct 5, 2015 | Kozin Marc D | Director | Buy | 4,800 | $10.79 | $51,792.00 | +30.5% | |
| Sep 9, 2015 | Fisher Mary | Director | Buy | 6,100 | $16.49 | $100,589.00 | +1,937% | |
| Sep 8, 2015 | Kozin Marc D | Director | Buy | 3,000 | $17.60 | $52,800.00 | +25.8% | |
| Aug 24, 2015 | Dipp Michelle | Chief Executive Officer | Buy | 300 | $18.56 | $5,568.00 | - | |
| May 26, 2015 | Dipp Michelle | Chief Executive Officer | Buy | 300 | $31.02 | $9,306.00 | - | |
| Apr 9, 2015 | Tzianabos Arthur74 | President And CSO | Buy | 225 | $28.77 | $6,473.25 | +128.6% | |
| Apr 9, 2015 | McNeely Theresa | EVP, Chief Comm. Officer | Buy | 400 | $29.29 | $11,717.14 | +229.9% | |
| Apr 8, 2015 | Tzianabos Arthur74 | President And CSO | Buy | 175 | $28.04 | $4,907.00 | New | |
| Apr 8, 2015 | Kozin Marc D | Director | Buy | 3,000 | $28.45 | $85,350.00 | +36.2% |